Latest AI and machine learning research in dementia for healthcare professionals.
Low-cost, scalable screening for dementia remains an open problem. Imaging-based diagnosis is costly...
Real-world decision-making rarely occurs with perfect information. Instead, individuals must constan...
Electroencephalography (EEG) is a promising tool for automated detection of mild cognitive impairmen...
Alzheimer's disease is a leading cause of death with no cure. Therefore, early detection is critical...
Alzheimer's disease (AD) progression is a longitudinal process with subtle pathological cues in the ...
Dementia affects more than 55 million people worldwide, and its progressive decline is difficult to ...
Alzheimer's disease (AD) causes amyloid formation, neuritic dystrophy, gliosis, synapse loss, behavi...
Access to holistic, multimodal data improves the performance of Artificial Intelligence (AI) in medi...
Causal discovery recovers directed structure from observational data and is increasingly used in cli...
Care robots are increasingly being introduced into healthcare settings, raising important questions ...
Identifying reliable Alzheimer's disease (AD) markers typically requires manual, labor-intensive tra...
As populations age, cognitive decline from mild cognitive impairment (MCI) to dementia is a defining...
EEG-based machine learning shows promise for neurodegenerative disease classification, but robustnes...
Background: Dementia caregiving carries substantial emotional and psychological consequences, but mo...
Accurate identification of Alzheimers disease (AD) using resting-state functional magnetic resonance...
Activities of daily living (ADLs) provide important indicators of functional decline in people livin...
Acoustic biomarkers show promise for detecting Alzheimer's Disease (AD), yet whether the cues drivin...
Pretrained EEG foundation models are increasingly proposed for clinical decoding, but their transfer...
INTRODUCTION: Cognitive syndrome diagnosis (Normal, Mild Cognitive Impairment (MCI), Dementia) is im...
INTRODUCTION: The biomarker-based amyloid/ tau/ neurodegeneration (A/T/N) framework has become a pop...
Introduction: Cerebral amyloid angiopathy (CAA) is characterized by amyloid-beta deposition in corti...